[Correspondence] Access to data in industry-sponsored trials
Source: The Lancet
The importance of transparency and data sharing in clinical research is increasingly emphasised, and public funders increasingly require that all data from publicly sponsored research are made available. The same cannot be said for industry-sponsored trials, for which the sponsors often own the data and the academic authors have limited publication rights.